Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 23, 2023

Safety of and Patient Experience With At-Home Infusion of Ocrelizumab for MS

Annals of Clinical and Translational Neurology


Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Clinical and Translational Neurology
Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis
Ann Clin Transl Neurol 2023 Feb 22;[EPub Ahead of Print], B Barrera, H Simpson, E Engebretson, S Sillau, B Valdez, J Parra-González, RC Winger, LA Epperson, A Banks, K Pierce, M Spotts, K O'Gean, E Alvarez, R Gross, AL Piquet, T Schreiner, JR Corboy, J Pei, TL Vollmer, KV Nair

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading